challenges with immunotherapy in aml: target antigen selection, t-cell exhaustion and more
Published 1 year ago • 213 plays • Length 2:15Download video MP4
Download video MP3
Similar videos
-
2:05
challenges with immunotherapy in aml: on-target, off-tumor toxicity
-
1:12
key challenges in immunotherapy for aml
-
1:44
challenges in developing car-t therapy for aml
-
2:23
an update on car-t therapy in aml: challenges & emerging strategies
-
1:48
the challenges of choosing the right target antigen in aml compared to all
-
7:46
updates in aml treatment and research from asco 2023
-
2:30
new leukemia treatment gives hope to cancer sufferers
-
19:39
t-cell engagers: targets, challenges and opportunity
-
25:18
addressing the major challenges to car-t therapy in aml
-
2:08
challenges with car-t therapy in aml & insights into if-better-gated car-t cells
-
2:33
novel immunotherapies in aml and insights into the future of the treatment landscape
-
4:16
the challenges with car t-cell therapy for t-all and the progress made to overcome these challenges
-
0:53
challenges with bringing novel immune therapies to mds
-
1:18
an insight into the challenges in prolonging remission in aml
-
1:07
challenges in treating aml
-
1:11
adoptive cellular therapy in aml: challenges and different approaches
-
1:13
the challenges in treating aml with car t-cell therapy
-
6:43
novel mitochondrial targets being explored in aml & strategies to overcome resistance to venetoclax
-
14:23
highlights from day 2: addressing challenges in car-t therapy for all, aml, cll & more…
-
1:27
challenges in car-t therapy for myeloid malignancies
-
1:41
the challenges with implementing car-t into the aml treatment landscape
-
1:12
contemporary challenges in polycythemia vera management